Trials / Completed
CompletedNCT01386164
Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to analyze and compare the immunogenicity of Bivalent and Tetravalent vaccines against Human Papillomavirus in HIV-infected adult persons.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Gardasil | Subjects will receive three doses of the study vaccine administered intramuscularly according to a Day 0, Week 6, and Month 6 vaccination schedule. |
| BIOLOGICAL | Cervarix | Subjects will receive three doses of the study vaccine administered intramuscularly according to a Day 0, Week 6, and Month 6 vaccination schedule. |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2012-12-01
- Completion
- 2013-08-01
- First posted
- 2011-06-30
- Last updated
- 2013-08-16
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01386164. Inclusion in this directory is not an endorsement.